期刊文献+

冠心病病人血清超敏C反应蛋白、尿酸和三酰甘油水平检测 被引量:10

MEASUREMENT OF SERUM hsCRP,UA AND TG IN PATIENTS WITH CORONARY HEART DISEASE
下载PDF
导出
摘要 目的探讨冠心病病人空腹血清超敏c反应蛋白(hsCRP)、尿酸(UA)和三酰甘油(TG)水平改变及其相关关系。方法抽取49例冠心病病人空腹肘静脉血5mL,分离血清后用全自动生化分析仪分别测定血清hsCRP、UA及TG水平,并随机选择30例正常体检者作为对照。结果冠心病病人血清hsCRP、UA和TG与对照组相比均显著升高,差异有显著性(t=2.294~2.926,P<0.05)。49例冠心病病人中hsCRP、UA和TG水平超出正常参考范围的人数分别为21、15和18例,三者间差异无显著性(X^2=1.581,P>0.05)。Person相关分析表明,冠心病病人3项指标间无明显相关性(r=-0.18~0.60,P>0.05)。结论血清hsCRP、UA和TG升高分别县冠心病的独立危险因素,三者联合检测将有助于冠心病的诊断、治疗和预后判定。 Objective To assess the levels of serum hsCRP, UA and TG in patients with coronary heart disease (CHD) and their correlativity. Methods Venous blood (5 mL) was collected from the CHD patients (n=49) and normal healthy adults (n=30) separately. Serum hsCRP, UA and TG were assessed by automatic biochemistry analyzer. Results The levels of hsCRP, UA and TG in the patients were significantly higher than those of the normal healthy adults (t= 2. 294-2. 926, P〈 0.05). The positive rates of hsCRP, UA and TG in the patients were 43% (21/49), 31% (15/49) and 37% (18/49) respectively, the differences among them were not significant (r= -0. 18-0. 60, P〉0. 05). Conclusion Increase of the levels of serum hsCRP, UA and TG is an independent risk factor which separately influence on patients with coronary heart disease. Combined assessments of the above parameters are of clinical significance in the diagnosis and treatment of the patients.
出处 《青岛大学医学院学报》 CAS 2007年第1期66-67,共2页 Acta Academiae Medicinae Qingdao Universitatis
关键词 冠状动脉疾病 C反应蛋白质 尿酸 甘油三酯类 coronary artery disease C-reactive protein uric acid triglycerides
  • 相关文献

参考文献6

二级参考文献18

  • 1李秀峰.尿酸冠心病的一个危险因子[J].美国医学会杂志(中文版),1994,13(4):189-190. 被引量:31
  • 2Gurfinkel E, Altman R, Scazziota A, et al. Importance of thrombosis and thrombolysis in silent ischenmia: comparison of patients with acute myocardial infarction and unstable angina[J]. Br Heart J,1994,71:151. 被引量:1
  • 3Lopez Y, Paloma MJ, Rifon J, et al. Measurement of prothrombotic markers in the assessment of acquired hypercoagulable states[J]. Throm Res,1999,93:71. 被引量:1
  • 4Hoffmeister HM, Jur M, Ruf-lehmann M, et al. Endothelial tissue-type plasminogen activator release in coronary heart disease: transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction[J]. J Am Coll Cardiol,1998,31:547. 被引量:1
  • 5Torzewski J,Torzewki M,Bowyer DE,et al. C-reactive protein frequently colocalizes with the terminal complement complex in the initima of early atherosclerotic lesions or human coronary arteries[J]. Arterioscler Thromb Vasc Biol,1998,18:1386. 被引量:1
  • 6Abdelmonttablebh I,Danchin N,Ilardo C,et al. C-reactive protein and coronary artery disease:additional evidence of the implication of and inflammatory process in acyte coronary syndromes[J]. Am Heart J,1999,137:246. 被引量:1
  • 7Onat A,Sansoy V,Yildirim B,et al. C-reactive protein and coronary heart disease in Western Turkey[J]. Am J Cardiol,2001,88:601. 被引量:1
  • 8US Departmentof Healthand Human Services Monograph,1996年,30页 被引量:1
  • 9Hatanaka K,Pathol Int,1995年,45卷,631页 被引量:1
  • 10Liuzzo G,New Engl J Med,1994年,331卷,417页 被引量:1

共引文献457

同被引文献72

引证文献10

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部